Turning Point Therapeutics, Inc. Marketable Securities (Current)
Turning Point Therapeutics, Inc. had Marketable Securities (Current) of $528.14 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2022-08-08
- 2022-06-30: Marketable Securities, Current $528.14M.
- 2022-03-31: Marketable Securities, Current $608.65M.
- 2021-12-31: Marketable Securities, Current $553.70M.
- 2021-09-30: Marketable Securities, Current $631.81M.
| Period end | Marketable Securities, Current |
|---|---|
| 2022-06-30 | $528.14M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $608.65M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $553.70M 10-Q · filed 2022-08-08 |
| 2021-09-30 | $631.81M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $651.76M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $645.61M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $568.41M 10-K · filed 2022-02-28 |
| 2020-09-30 | $399.11M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $239.92M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $350.94M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $360.96M 10-K · filed 2021-03-01 |
| 2019-09-30 | $251.15M 10-Q · filed 2019-11-04 |